Abstract:The molecular and genetic events that contribute to the genesis and progression of cutaneous malignant melanoma are poorly understood, attributable in large part to the different genetic alterations accompanying tumorigenesis. Inhibitor of kinase 4a (INK4a) is often inactivated in families with hereditary melanoma. Loss of INK4a/alternate reading frame (ARF) in mice is associated with increased incidence of other tumors such as lymphoma and fibrosarcoma. However, the incidence of melanoma in INK4a/ARF-deficient mice is very low. Our previous studies have revealed that the CXC chemokine, CXCL1, is overexpressed in human malignant melanoma cells and is linked to transformation of immortalized murine melanocytes. To study the direct role of CXCL1 on the genesis of primary melanoma lesions, transgenic mouse lines were established that express the murine homologue of CXCL1, murine macrophage inflammatory protein 2 (MIP-2), under the transcriptional control of the tyrosinase promoter/enhancer (Tyr-MIP-2) in the mice that were deficient or not deficient for INK4a/ARF. Strong MIP-2 immunoreactivity was associated with pigmented melanocytes in the hyperproliferative hair follicles in the Tyr-MIP-2 transgenic mice, and the level of MIP-2 expression was similar in both INK4a/ARF heterozygous or wild-type mice. After treatment of mice with 7,12-dimethylbenz(a)anthracene, cutaneous melanomas formed in 12% (17/145) of the Tyr-MIP-2 transgene-positive mice, whereas only 2% (3/146) of the Tyr-MIP-2 transgene-negative mice developed melanoma. When melanocytes cultured from MIP-2 transgenic mice null for INK4a/ARF were transplanted into nude mice, melanoma formation occurred in 83% (10/12) of the cases with a latency period of 3 months. However, no melanoma lesions arose in nude mice injected with INK4a/ARF -/- melanocytes, which did not express the MIP-2 transgene. Our results demonstrate that constitutive expression of MIP-2 in INK4a/ARF-deficient melanocytes facilitates formation of malignant melanoma.

Independent genetic control of early and late stages of chemically induced skin tumors in a cross of a Japanese wild-derived inbred mouse strain, MSM/Ms.

Genome-wide Screening of Aberrant DNA Methylation Which Associated with Gene Expression in Mouse Skin Cancers.

A Subset of Skin Tumor Modifier Loci Determines Survival Time of Tumor-Bearing Mice.

Data from Genome-Wide Association and Fine Mapping of Genetic Loci Predisposing to Colon Carcinogenesis in Mice

Allele-Specific Hras Mutations And Genetic Alterations At Tumor Susceptibility Loci In Skin Carcinomas From Interspecific Hybrid Mice

Candidate lung tumor susceptibility genes identified through whole-genome association analyses in inbred mice.

Effects of genetic background on tumorigenesis in p53-deficient mice

Induction Of Melanoma In Murine Macrophage Inflammatory Protein 2 Transgenic Mice Heterozygous For Inhibitor Of Kinase/Alternate Reading Frame

Genetic Variants of Tgfb1 Act As Context-Dependent Modifiers of Mouse Skin Tumor Susceptibility

A Mouse Skin Multistage Carcinogenesis Model Reflects The Aberrant Dna Methylation Patterns Of Human Tumors

The MutSβ complex is a modulator of p53-driven tumorigenesis through its functions in both DNA double-strand break repair and mismatch repair

Gain of Function of a p53 Hot Spot Mutation in a Mouse Model of Li-Fraumeni Syndrome

Diverse tumour susceptibility in Collaborative Cross mice: identification of a new mouse model for human gastric tumourigenesis.

A Tmprss2-CreERT2 Knock-In Mouse Model for Cancer Genetic Studies on Prostate and Colon

Mouse models to investigate in situ cell fate decisions induced by p53

Increased susceptibility to mammary carcinogenesis and an opposite trend in endometrium in Trp53 heterozygous knockout female mice by backcrossing the BALB/c strain onto the background C3H strain

Polymorphic Genetic Control of Tumor Invasion in a Mouse Model of Pancreatic Neuroendocrine Carcinogenesis

Mutually Exclusive Mutations Of The Pten And Ras Pathways In Skin Tumor Progression

The Establishment of Esophageal Precancerous Lesion Model by Using p53 Conditional Knockout Mouse in Esophageal Epithelium

Allele-Specific Deletions in Mouse Tumors Identify Fbxw7 As Germline Modifier of Tumor Susceptibility

Control Of Genomic Instability And Epithelial Tumor Development By The P53-Fbxw7/Cdc4 Pathwayle